HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin requirements in lipodystrophic diabetes.

Abstract
A ten-fold increase in daily insulin requirements during the administration of total parenteral nutrition (TPN) is described in a patient with congenital generalized lipodystrophy, insulin-requiring diabetes mellitus, and acanthosis nigricans during an episode of acute pancreatitis secondary to hypertriglyceridaemia. After a period of 13 days on TPN, insulin requirements increased dramatically to an average of 1428 units per day for a period of 12 days, to achieve a mean blood glucose level of 10.9 mmol l-1. When the patient resumed feeding and the TPN was discontinued, the average daily insulin requirement was 104 units with a mean 24 h blood glucose of 11.8 mmol l-1. Parenteral administration of energy substrates in a rare case of diabetes mellitus and congenital lipodystrophy complicated by acute pancreatitis resulted in a severe insulin insensitive state due to the combination of the hypermetabolism conferred by the pancreatitis plus transient impairments of the glucose disposal mechanism by the energy substrates provided.
AuthorsP F Mora, L C Ramirez, D Lender, P Raskin
JournalDiabetic medicine : a journal of the British Diabetic Association (Diabet Med) Vol. 10 Issue 9 Pg. 863-5 (Nov 1993) ISSN: 0742-3071 [Print] England
PMID8281734 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Blood Glucose
  • Insulin
Topics
  • Acanthosis Nigricans (complications)
  • Acute Disease
  • Adult
  • Blood Glucose (metabolism)
  • Diabetes Mellitus, Type 1 (blood, complications, drug therapy)
  • Dose-Response Relationship, Drug
  • Eating
  • Female
  • Humans
  • Hypertriglyceridemia (complications)
  • Insulin (therapeutic use)
  • Lipodystrophy (complications)
  • Pancreatitis (etiology, therapy)
  • Parenteral Nutrition, Total

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: